Intrinsic Value of S&P & Nasdaq Contact Us

DENTSPLY SIRONA Inc. XRAY NASDAQ

NASDAQ Global Select • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
32/100
1/7 Pass
SharesGrow Intrinsic Value
$14.39
+17.8%
Analyst Price Target
$13.33
+9.1%

DENTSPLY SIRONA Inc. (XRAY) — Analyst outlook / Analyst consensus target is. Based on 31 analyst ratings, the consensus is bullish — 12 Buy, 18 Hold, 1 Sell.

The consensus price target is $13.33 (low: $12.00, high: $16.00), representing an upside of 9.1% from the current price $12.22.

Analysts estimate Earnings Per Share (EPS) of $1.84 and revenue of $3.81B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-4.48 vs est $1.83 (missed -344.1%). 2025: actual $-3.00 vs est $1.60 (missed -287.3%). Analyst accuracy: 0%.

XRAY Stock — 12-Month Price Forecast

$13.33
▲ +9.08% Upside
Average Price Target
Based on 31 Wall Street analysts offering 12-month price targets for DENTSPLY SIRONA Inc., the average price target is $13.33, with a high forecast of $16.00, and a low forecast of $12.00.
The average price target represents a +9.08% change from the last price of $12.22.
Highest Price Target
$16.00
Average Price Target
$13.33
Lowest Price Target
$12.00

XRAY Analyst Ratings

Hold
31
Ratings
12 Buy
18 Hold
1 Sell
Based on 31 analysts giving stock ratings to DENTSPLY SIRONA Inc. in the past 3 months
Rating breakdown
Buy
12 39%
Hold
18 58%
Sell
1 3%
39%
Buy
12 analysts
58%
Hold
18 analysts
3%
Sell
1 analysts

EPS Estimates — XRAY

0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual –$4.48 vs Est $1.83 ▼ 141.0% off
2025 Actual –$3.00 vs Est $1.60 ▼ 153.4% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect the company to turn profitable.

Revenue Estimates — XRAY

99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $3.793B vs Est $3.809B ▼ 0.4% off
2025 Actual $3.680B vs Est $3.645B ▲ 0.9% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message